קנדה - צרפתית - Health Canada

fresenius kabi canada ltd - pamidronate disodique - solution - 6mg - pamidronate disodique 6mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

fresenius kabi canada ltd - pamidronate disodique - solution - 9mg - pamidronate disodique 9mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

sandoz canada incorporated - pamidronate disodique - solution - 3mg - pamidronate disodique 3mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

sandoz canada incorporated - pamidronate disodique - solution - 6mg - pamidronate disodique 6mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

sandoz canada incorporated - pamidronate disodique - solution - 9mg - pamidronate disodique 9mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

jamp pharma corporation - acide alendronique (alendronate sodique) - comprimé - 70mg - acide alendronique (alendronate sodique) 70mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

angita pharma inc. - acide alendronique (alendronate sodique) - comprimé - 70mg - acide alendronique (alendronate sodique) 70mg - bone resorption inhibitors

קנדה - צרפתית - Health Canada

rockwell medical inc - fer (citrate ferrique de pyrophosphate) - solution - 1.5mg - fer (citrate ferrique de pyrophosphate) 1.5mg - iron preparations

האיחוד האירופי - צרפתית - EMA (European Medicines Agency)

teva b.v. - acide zolédronique - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - médicaments pour le traitement des maladies osseuses - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. le traitement de la maladie de paget de l'os chez les adultes.

שווייץ - צרפתית - Swissmedic (Swiss Agency for Therapeutic Products)

b.e.imaging.ag - tetranatrii diphosphas anhydricus - markierungsbesteck - praeparatio cryodesiccata: tetranatrii diphosphas decahydricus 20 mg corresp. tetranatrii diphosphas anhydricus 11.9 mg, stannosi chloridum dihydricum, acidum hydrochloridum concentratum, natrii hydroxidum ad ph, nitrogenium, pro vitro corresp. natrium 4.12 mg. - blutpoolszintigraphie - radiopharmazeutika